Development of a TaqMan Allelic Discrimination Assay for detection of Single Nucleotides Polymorphisms associated with anti-malarial drug resistance

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Kamau, Edwin ^a   Alemayehu, Saba ^a   Feghali, Karla C ^a   Tolbert, Ladonna S ^a   Ogutu, Bernard ^b   Ockenhouse, Christian F ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CLINICAL ARTICLE; CODON; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; LIMIT OF DETECTION; MIXED INFECTION; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TAQMAN ALLELIC DISCRIMINATION ASSAY; ALLELE; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; EVALUATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; METHODOLOGY; PARASITOLOGY;

ALLELES; ANTIMALARIALS; DRUG RESISTANCE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY;

EID: 84856021050     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-23     Document Type: Article

References (30)

1. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Guerin P, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama W, Ford N, White N, Lancet Infect Dis 2002 2 564 573 10.1016/S1473-3099(02)00372-9 12206972 (Pubitemid 34966359)
2. Drug resistance hampers our capacity to roll back malaria. Olliaro P, Clin Infect Dis 2005 15 247 257
3. World Health Organization, Global report on antimalarial drug efficacy and drug resistance World Health Organization, Geneva 2010
4. The anatomy of a malaria disaster: drug policy choice and mortality in African children. Hastings IM, Korenromp EL, Bloland PB, Lancet Infect Dis 2007 7 739 748 10.1016/S1473-3099(07)70214-1 17884732 (Pubitemid 47610756)
5. Molecular markers as indicators of antimalarial drug failure rates. Hastings IM, Trop Med Int Health 2007 12 1298 1301 10.1111/j.1365-3156.2007. 01928.x 17949397 (Pubitemid 350191138)
6. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, Trends Parasitol 2001 17 582 588 10.1016/S1471-4922(01)02085-2 11756042 (Pubitemid 34088118)
7. The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea. Marfurt J, Muller I, Sie A, Oa O, Reeder JC, Smith TA, Beck HP, Genton B, Malar J 2008 7 61 10.1186/1475-2875-7-61 18423045 (Pubitemid 351678131)
8. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. Crameri A, Marfurt J, Mugittu K, Maire N, Regos A, Coppee JY, Sismeiro O, Burki R, Huber E, Laubscher D, Puijalon O, Genton B, Felger I, Beck HP, J Clin Microbiol 2007 45 3685 3691 10.1128/JCM.01178-07 17804664 (Pubitemid 350156867)
9. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
10. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, Malar J 2007 6 121 10.1186/1475-2875-6-121 17822535 (Pubitemid 47566322)
11. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring resistance. Marfurt J, Smith AT, Hastings MI, Muller I, Sie A, Oa O, Baisor M, Reeder CJ, Beck H, Genton B, Malar J 2010 9 8 10.1186/1475-2875-9-8 20053293
12. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolatereductase: polymerase chain reaction methods for surveillance in Africa. Plowe VC, Djimde A, Bouare M, Doumbo O, Wellems ET, Am J Trop Med Hyg 1995 52 565 568 7611566
13. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721 (Pubitemid 34107252)
14. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthetase in sulfadoxine-resistant malaria. Triglia T, Wang P, Sims P, Hyde J, Cowman AF, EMBO J 1998 17 3807 3815 10.1093/emboj/17.14.3807 9669998 (Pubitemid 28333967)
15. A molecular marker for chloroquine-resistant falciparum malaria. Djimde' A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock AD, Wellems TE, Plowe CV, Coulibaly D, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
16. Chloroquine resistance in P. falciparum malaria parasites conferred by pfcrt mutations. Sidhu AB, Verdier-Pinard D, Fidock DA, Science 2002 298 210 213 10.1126/science.1074045 12364805
17. Defining the role of PfCRT in P. falciparum chloroquine resistance. Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA, Mol Microbiol 2005 56 323 333 10.1111/j.1365-2958.2005.04556.x 15813727 (Pubitemid 40516774)
18. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Duraisingh MT, Cowman AF, Acta Trop 2005 94 181 190 10.1016/j.actatropica.2005. 04.008 15876420 (Pubitemid 40720325)
19. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Ranford-Cartwright LC, Johnston KL, Abdel-Muhsin AM, Khan BK, Babiker HA, Trans R Soc Trop Med Hyg 2002 96 568 572 10.1016/S0035-9203(02)90446-3 12474492 (Pubitemid 35386238)
20. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. Nair S, Brockman A, Paiphun L, Nosten F, Anderson TJ, Int J Parasitol 2002 32 852 858 10.1016/S0020-7519(02)00033-4 12062556 (Pubitemid 34615878)
21. Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. Decuypere S, Elinck E, Van Overmeir C, Talisuna AO, D'Alessandro U, Dujardin JC, J Infect Dis 2003 188 1245 1249 10.1086/378521 14551896 (Pubitemid 37338990)
22. Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Durand R, Eslahpazire J, Jafari S, Delabre JF, Marmorat-Khuong A, di Piazza JP, Le Bras J, Antimicrob Agents Chemother 2000 44 3461 3464 10.1128/AAC.44.12.3461-3464.2000 11083660 (Pubitemid 33009514)
23. Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum. de Monbrison F, Raynaud D, Latour-Fondanaiche C, Staal A, Favre S, Kaiser K, Peyron F, Picot S, J Microbiol Methods 2003 54 391 401 10.1016/S0167-7012(03)00086-1 12842486 (Pubitemid 36780924)
24. A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Purfield A, Nelson A, Laoboonchai A, Congpuong K, McDaniel P, Miller RS, Welch K, Wongsrichanalai C, Meshnick SR, Malar J 2004 7 3 9
25. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. Crameri A, Marfurt J, Mugittu K, Maire N, Regos A, Coppee JY, Sismeiro O, Burki R, Huber E, Laubscher D, Puijalon O, Genton B, Felger I, Beck HP, J Clin Microbiol 2007 45 3685 3691 10.1128/JCM.01178-07 17804664 (Pubitemid 350156867)
26. Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children. Withers MR, McKinney D, Ogutu BR, Waitumbi JN, Milman JB, Apollo OJ, Allen OG, Tucker K, Soisson LA, Diggs C, Leach A, Wittes J, Dubovsky F, Stewart VA, Remich SA, Cohen J, Ballou WR, Holland CA, Lyon JA, Angov E, Stoute JA, Martin SK, Heppner DG Jr, MSP-1 Malaria Vaccine Working Group, PLoS Clin Trials 2006 1e32
27. Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of plasmodium by amplifying RNA and DNA of the 18S rRNA genes. Kamau E, Tolbert LS, Kortepeter L, Pratt M, Nyakoe N, Muringo L, Ogutu B, Waitumbi JN, Ockenhouse CF, J Clin Microbiol 2011 49 2946 2953 10.1128/JCM.00276-11 21653767
28. Real-time PCR methods for monitoring antimalarial drug resistance. Wilson PE, Alker AP, Meshnick SR, Trends Parasitol 2005 21 278 83 10.1016/j.pt.2005. 04.007 15922249 (Pubitemid 40726319)
29. A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Daniels R, Volkman SK, Milner DA, Mahesh N, Neafsey DE, Park DJ, Rosen D, Angelino E, Sabeti PC, Wirth DF, Wiegand RC, Malar J 2008 7 223 10.1186/1475-2875-7-223 18959790
30. Analytical validation of genotyping assays in the biomarker laboratory. Isler JA, Vesterqvist OE, Burczynski ME, Pharmacogenomics 2007 8 353 368 10.2217/14622416.8.4.353 17391073 (Pubitemid 46585498)